# Study of Endostar Combined With TP Regimen for Esophageal Cancer

> **NCT04164797** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Xi'an Jiaotong University** · enrollment: 402 (estimated)

## Conditions studied

- Patients With Esophageal Cancer(Ⅱ-Ⅲ)

## Interventions

- **DRUG:** endostar+chemoradiotherapy
- **OTHER:** chemoradiotherapy

## Key facts

- **NCT ID:** NCT04164797
- **Lead sponsor:** Second Affiliated Hospital of Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-25
- **Primary completion:** 2021-07-13
- **Final completion:** 2021-07-13
- **Target enrollment:** 402 (ESTIMATED)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04164797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04164797, "Study of Endostar Combined With TP Regimen for Esophageal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04164797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*